12.51
前日終値:
$12.36
開ける:
$12.38
24時間の取引高:
606.02K
Relative Volume:
0.60
時価総額:
$657.02M
収益:
$1.02B
当期純損益:
$-757.20M
株価収益率:
-0.8476
EPS:
-14.76
ネットキャッシュフロー:
$-257.90M
1週間 パフォーマンス:
+0.72%
1か月 パフォーマンス:
+15.39%
6か月 パフォーマンス:
+76.08%
1年 パフォーマンス:
+21.90%
Emergent Biosolutions Inc Stock (EBS) Company Profile
名前
Emergent Biosolutions Inc
セクター
電話
240-631-3200
住所
300 PROFESSIONAL DR, GAITHERSBURG, MD
EBS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
EBS
Emergent Biosolutions Inc
|
12.51 | 649.15M | 1.02B | -757.20M | -257.90M | -14.76 |
|
ZTS
Zoetis Inc
|
125.90 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.02 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.95 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
496.72 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-08-22 | 開始されました | Rodman & Renshaw | Buy |
| 2024-03-07 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-11-20 | 再開されました | JP Morgan | Underweight |
| 2023-08-29 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2023-04-10 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-03-17 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2022-11-10 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-04-29 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2022-01-20 | アップグレード | The Benchmark Company | Hold → Buy |
| 2021-11-08 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2021-05-05 | ダウングレード | Argus | Buy → Hold |
| 2021-04-07 | 開始されました | The Benchmark Company | Buy |
| 2021-02-24 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2021-02-19 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2021-01-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-09-14 | 再開されました | JP Morgan | Neutral |
| 2020-07-31 | 繰り返されました | Chardan Capital Markets | Buy |
| 2019-09-12 | 開始されました | Guggenheim | Buy |
| 2019-09-04 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2018-11-02 | アップグレード | Goldman | Neutral → Buy |
| 2018-08-03 | 繰り返されました | Chardan Capital Markets | Buy |
| 2018-06-13 | 開始されました | Argus | Buy |
| 2018-04-25 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2018-01-24 | 開始されました | Goldman | Neutral |
| 2018-01-16 | 繰り返されました | Chardan Capital Markets | Buy |
| 2016-06-28 | 繰り返されました | Singular Research | Buy |
| 2016-04-15 | 開始されました | Chardan Capital Markets | Buy |
| 2016-03-28 | 開始されました | Singular Research | Buy |
| 2016-02-19 | 開始されました | Wells Fargo | Outperform |
| 2014-05-15 | 開始されました | Summer Street Research | Buy |
| 2011-05-31 | 繰り返されました | WBB Securities | Strong Buy |
| 2011-01-10 | 繰り返されました | Wedbush | Outperform |
| 2010-11-05 | 繰り返されました | Wedbush | Outperform |
| 2010-08-18 | アップグレード | WBB Securities | Buy → Strong Buy |
| 2010-08-06 | 繰り返されました | Caris & Company | Buy |
すべてを表示
Emergent Biosolutions Inc (EBS) 最新ニュース
EBIT per share of Emergent BioSolutions Inc. – LSE:0IGA - TradingView — Track All Markets
Assenagon Asset Management S.A. Has $498,000 Stock Position in Emergent Biosolutions Inc. $EBS - MarketBeat
Emergent Biosolutions (NYSE:EBS) Stock Price Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Emergent BioSolutions Inc. (NYSE:EBS) Surges 28% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
EBS (NYSE: EBS) insider files Rule 144 to sell 104,695 shares - Stock Titan
Can Emergent BioSolutions Inc. stock beat analyst upgrades2025 Risk Factors & Reliable Entry Point Alerts - Улправда
How risky is Emergent BioSolutions Inc. stock nowJuly 2025 Pullbacks & Smart Money Movement Alerts - Улправда
Is Emergent BioSolutions Inc. stock recession proofEarnings Overview Summary & Real-Time Volume Analysis Alerts - Улправда
Is Emergent BioSolutions Inc. stock a buy before product launchesQuarterly Risk Review & Technical Analysis for Trade Confirmation - Улправда
Why Emergent BioSolutions Inc. stock is a must watch ticker2025 Support & Resistance & Free Weekly Watchlist of Top Performers - Улправда
Can Emergent BioSolutions Inc. stock survive global slowdownGlobal Markets & Consistent Income Trade Recommendations - Улправда
Institutional investors have a lot riding on Emergent BioSolutions Inc. (NYSE:EBS) with 73% ownership - simplywall.st
Earnings Risk: Will Emergent BioSolutions Inc. stock gain from government policiesMarket Growth Report & Risk Controlled Stock Pick Alerts - Улправда
Will Emergent BioSolutions Inc. stock profit from AI boom2025 Trade Ideas & Intraday High Probability Alerts - Улправда
Is Emergent BioSolutions Inc. (ER4) stock vulnerable to rate hikes2025 Year in Review & Safe Capital Growth Plans - DonanımHaber
What is the fair value of Emergent BioSolutions Inc. stock nowJuly 2025 Rallies & Smart Allocation Stock Reports - DonanımHaber
Is Emergent BioSolutions Inc. (ER4) stock a safe buy pre earningsWeekly Earnings Recap & AI Driven Stock Reports - DonanımHaber
How sustainable is Emergent BioSolutions Inc. stock dividend payoutStop Loss & Target Return Focused Stock Picks - Улправда
VP Lowry Surrenders 3,543 Of Emergent BioSolutions Inc [EBS] - TradingView — Track All Markets
Emergent BioSolutions (EBS) insider has shares withheld to cover taxes - Stock Titan
Emergent Biosolutions (NYSE:EBS) Earns Buy Rating from HC Wainwright - MarketBeat
EBS: HC Wainwright & Co. Reiterates Buy Rating and $15 Price Tar - GuruFocus
HC Wainwright & Co. Reiterates Emergent BioSolutions (EBS) Buy Recommendation - Nasdaq
Emergent Biosolutions (NYSE:EBS) Trading 5.9% HigherHere's Why - MarketBeat
Emergent BioSolutions Gains FDA Approval for Winnipeg Facility - The Globe and Mail
Energy Moves: Can Emergent BioSolutions Inc stock weather global recessionEarnings Growth Summary & Trade Opportunity Analysis Reports - moha.gov.vn
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site - The Manila Times
Emergent BioSolutions (NYSE: EBS) gains FDA OK for Winnipeg raxibacumab drug product site - Stock Titan
Emergent BioSolutions (NYSE: EBS) gains FDA approval for raxibacumab production - Stock Titan
Emergent BioSolutions Inc Stock Analysis and ForecastEvening Star Patterns & Low Risk Capital Growth Plans - earlytimes.in
Emergent Biosolutions (NYSE:EBS) Director Sells $263,148.48 in Stock - MarketBeat
Emergent BioSolutions (EBS) director reports option exercise and stock sales - Stock Titan
Emergent Biosolutions Q1 2025 Earnings Preview - MSN
EBS (NYSE: EBS) holder files Form 144 to sell 32,848 shares - Stock Titan
What makes Emergent BioSolutions Inc. stock appealing to growth investorsTrade Risk Report & AI Driven Stock Reports - Newser
Emergent Biosolutions Inc. $EBS Stock Holdings Increased by Geode Capital Management LLC - MarketBeat
How cyclical is Emergent BioSolutions Inc. (ER4) stock compared to rivalsMarket Risk Report & Free Reliable Trade Execution Plans - Newser
Will Emergent BioSolutions Inc. stock split again soonBull Run & Daily Risk Controlled Trade Plans - Newser
Will Emergent BioSolutions Inc. stock reach Wall Street targets2025 Big Picture & Advanced Swing Trade Entry Plans - Newser
How Emergent BioSolutions Inc. (ER4) stock behaves in tightening cyclesTrade Entry Summary & Daily Growth Stock Investment Tips - Newser
Will Emergent BioSolutions Inc. (ER4) stock extend growth storyJuly 2025 EndofMonth & Reliable Price Action Trade Plans - Newser
Published on: 2025-12-04 04:37:47 - Newser
Is Emergent BioSolutions Inc. (ER4) stock protected from inflationJuly 2025 Drop Watch & Low Drawdown Investment Strategies - Newser
Will Emergent BioSolutions Inc. (ER4) stock top growth indexesM&A Rumor & AI Driven Price Forecasts - Newser
EBS SEC FilingsEmergent Biosolutions Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Published on: 2025-12-03 01:19:03 - Newser
How Emergent BioSolutions Inc. stock compares to market leadersJuly 2025 Opening Moves & Technical Buy Zone Confirmations - Newser
Why ETFs are accumulating Emergent BioSolutions Inc. stockInsider Selling & Free Verified High Yield Trade Plans - Newser
Why Emergent BioSolutions Inc. stock is popular among millennialsInflation Watch & Weekly Top Stock Performers List - Newser
Emergent Biosolutions Inc (EBS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):